A 12-year-old Spanish male was referred to our department to elucidate the etiology of a congenital macrocytic anemia (MCV 104 fL; Hb 9.0 g/dL) with dyserythropoiesis, needing blood transfusions during the first 4 months of life, and mild thrombocytopenia (73 × 10 9 /L) with large platelets. At the age of 3 months, he presented: Hb 5.9 g/dL, reticulocytes 105 × 10 12 /L, peripheral blood smear with anisocytosis, poikilocytosis, and basophilic stippling. He has a low PK activity (45 % of normal). The bone marrow was suggestive of congenital dyserythropoietic anemia (CDA), with erythroid hyperplasia and dyserythropoiesis and orthochromatic erythroblasts showing an irregular nuclear contour and bi-or multinucleated erythroblasts; electronic microscopy identified vacuoles in the cytoplasm of erythroblasts.
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CDAs are rare forms of bone marrow failure syndromes characterized by ineffective erythropoiesis [1, 2] . There are three classical forms of CDA presentation due to mutations in CDANI, C15orf41, SEC23B, and KIF23 [3] [4] [5] and rarer forms associated with pathological variants in KLF1 and GATA1. GATA1 variants are associated with deregulation of erythroid and megakaryocytic lineages differentiation [6] [7] [8] .
We studied the patient and available family members ( Fig. 1) , results are summarized in Table 1 . Sequence analysis of CDANI, SEC23B, C15ORF41, KLF1, HBB, HBA was normal, in PKLR, we found a new pathological variant c.1284delA (Glu429Argfs*19) in the heterozygous state. His mother and sister were also heterozygous for PKLR c.1284delA. The heterogeneity of family's data affecting both erythroid and megakaryocytic lines prompted us to perform sequencing analysis of GATA1. An A to G transition (c.866 A > G) was identified in the propositus in hemizygous state. Interestingly, PK activity was also decreased in the GATA1 hemizygous relative studied (Table 1-III-2) . This pedigree illustrates the difference of the hematological manifestations among the propositus, carrier of mutations at the GATA1 and PKLR, and the other family males, presenting only the GATA1 mutation.
This novel GATA1 mutation results in the substitution of histidine for arginine (p.His289Arg) in the C-terminal zinc finger. This residue is conserved across GATA1 orthologs of various species, and bioinformatics analysis classifies the variant as pathological. The mutation was not detected in 100 normal chromosomes and was published by us in the GenBank (Accession Number KC733811). This is the first report of a CDA associated with a mutation in the GATA1 in a region coding for the Cterminal zinc finger domain of GATA1 protein, necessary for DNA binding [9] . GATA1 is an important transcription factor for hematopoiesis regulation, in particular for the erythroid and megakaryocyte lineages. Mutations affecting the C-terminal zinc finger domain are probably not as damaging as those affecting the N-terminal, which would account for the milder phenotypes of hemizygous males, with mild macrocytic anemia. To explain the more severe phenotype of the propositus comparatively to his affected male cousins, we hypothesize this is due to the co-inheritance of the mutated PKLR allele. In fact, the lower than expected PK activity may reflect the association of the PKLR mutated allele with a decreased PKLR expression due to the GATA1 mutation. This hypothesis is supported by the fact that the PK activity is also decreased in the GATA1 hemizygous (III-2). As previously reported, mutations in the PKLR gene GATA motifs, required for the R-PK promoter activity, disable the binding of the GATA1, decreasing the normal PKLR gene expression [10] . This is the first description how a heterozygous PK deficiency, otherwise harmless, can lead to 
